Nc1ccc(Oc2ccc(C34CC5CC(C3)CC(c3ccc(Oc6ccc(N)c(O)c6)cc3)(C5)C4)cc2)cc1O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?